Bayer has recently settled thousands of cases over claims the active ingredient in its Roundup weedkiller causes cancer, ...

German pharmaceutical and biotechnology group Bayer said on Thursday it had set aside an additional 1.2 billion euros ($1.37 ...

Crop science giant Bayer says it has settled 17,000 glyphosate cases so far and hopes for a supreme court ruling next year.

Investor concerns that Bayer's earnings were inflated by soccer player transfer fees rather than supported by its core ...

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET ...

The latest Market Talks covering Basic Materials. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ...

The additional financial provisions support Bayer’s stated goal to get glyphosate litigation and liabilities contained by ...

Bayer Aktiengesellschaft boosted 2025 sales outlook with pharma growth and lower litigation costs. Click for why BAYRY is an ...

Bayer was ordered to pay $2.25 billion after a jury unanimously found that the company’s weed killer, Roundup, was responsible for 49-year-old John McKivinson’s non-Hodgkin’s lymphoma diagnosis.

Bayer described the legislation as one strategy to address the "headwinds" it faces. About 167,000 legal claims against Bayer assert Roundup causes a cancer called non-Hodgkin's lymphoma, which ...

Bayer's federal preemption defense is key to resolving Roundup lawsuits. Bayer agreed to pay nearly $10 billion to settle most of an estimated 125,000 Roundup claims, but at least 30,000 cases remain.

Bayer agreed to pay nearly $10 billion to settle most of an estimated 125,000 Roundup claims, but thousands remain—and most are not cases handled by lead counsel in the multidistrict litigation.